Gene · 1672
Papers3,189
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 3,189
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Luminal microvesicles uniquely influence translocating bacteria after SIV infection. | Mucosal Immunol | 2021 | 33731830 | PubTator, text mining | PubMed |
| Increasing tumor budding in cholangiocarcinoma is associated with decreased disease-specific survival. | Hum Pathol | 2021 | 33727168 | PubTator, text mining | PubMed |
BET bromodomain inhibitors PFI-1 and JQ1 are identified in an epigenetic compound screen to enhance C9ORF72 gene expression and shown to ameliorate C9ORF72-associated pathological and behavioral abnormalities in a C9ALS/FTD model. | Clin Epigenetics | 2021 | 33726839 | PubTator, text mining | PubMed |
| Achieving clinical success with BET inhibitors as anti-cancer agents. | Br J Cancer | 2021 | 33723398 | PubTator, text mining | PubMed |
| Dissecting the Role of BET Bromodomain Proteins BRD2 and BRD4 in Human NK Cell Function. | Front Immunol | 2021 | 33717143 | PubTator, text mining | PubMed |
| Developmental exposure to chlordecone induces transgenerational effects in somatic prostate tissue which are associated with epigenetic histone trimethylation changes. | Environ Int | 2021 | 33711761 | PubTator, text mining | PubMed |
| Clinical Implications of Inflammation in Acute Myeloid Leukemia. | Front Oncol | 2021 | 33692956 | PubTator, text mining | PubMed |
| Helicobacter pylori-Induced Rev-erbα Fosters Gastric Bacteria Colonization by Impairing Host Innate and Adaptive Defense. | Cell Mol Gastroenterol Hepatol | 2021 | 33676046 | PubTator, text mining | PubMed |
| Up-Regulated Vitamin D Receptor by Pelargonium sidoides Extract EPs® 7630 Contributes to Rhinovirus Defense in Bronchial Epithelial Cells. | Pharmaceuticals (Basel) | 2021 | 33671804 | PubTator, text mining | PubMed |
| Integration of transcriptome analysis with pathophysiological endpoints to evaluate cigarette smoke toxicity in an in vitro human airway tissue model. | Arch Toxicol | 2021 | 33660061 | PubTator, text mining | PubMed |
| Sputum Proteome Signatures of Mechanically Ventilated Intensive Care Unit Patients Distinguish Samples with or without Anti-pneumococcal Activity. | mSystems | 2021 | 33653939 | PubTator, text mining | PubMed |
| Improving tumor budding reporting in colorectal cancer: a Delphi consensus study. | Virchows Arch | 2021 | 33650042 | PubTator, text mining | PubMed |
| DEFB1 gene polymorphisms modify vitiligo extent and response to NB-UVB phototherapy. | Dermatol Ther | 2021 | 33647170 | PubTator, text mining | PubMed |
Design, synthesis, and biological evaluation of novel 4,4-difluoro-1-methyl-N, 6-diphenyl-5, 6-dihydro-4H-pyrimido [4, 5-b] [1, 2, 4] triazolo [4, 3-d] [1, 4] diazepin-8-amine derivatives as potential BRD4 inhibitors. | Chem Biol Drug Des | 2021 | 33638254 | PubTator, text mining | PubMed |
| Discovery and characterization of bromodomain 2-specific inhibitors of BRDT. | Proc Natl Acad Sci U S A | 2021 | 33637650 | PubTator, text mining | PubMed |
Interplay of stromal tumor-infiltrating lymphocytes, normal colonic mucosa, cancer-associated fibroblasts, clinicopathological data and the immunoregulatory molecules of patients diagnosed with colorectal cancer. | Cancer Immunol Immunother | 2021 | 33625532 | PubTator, text mining | PubMed |
| Bromodomain proteins regulate human cytomegalovirus latency and reactivation allowing epigenetic therapeutic intervention. | Proc Natl Acad Sci U S A | 2021 | 33619107 | PubTator, text mining | PubMed |
| Targeting Bromodomain and Extraterminal Proteins for Drug Discovery: From Current Progress to Technological Development. | J Med Chem | 2021 | 33616410 | PubTator, text mining | PubMed |
| Distinct Antiviral Properties of Two Different Bacterial Lysates. | Can Respir J | 2021 | 33613792 | PubTator, text mining | PubMed |
| Immunomodulatory Agents Combat Multidrug-Resistant Tuberculosis by Improving Antimicrobial Immunity. | J Infect Dis | 2021 | 33606878 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1672/papers?page=53